CR8439A - Metodo para mejorar la eficacia de drogas terapeuticas radio rotuladas - Google Patents
Metodo para mejorar la eficacia de drogas terapeuticas radio rotuladasInfo
- Publication number
- CR8439A CR8439A CR8439A CR8439A CR8439A CR 8439 A CR8439 A CR 8439A CR 8439 A CR8439 A CR 8439A CR 8439 A CR8439 A CR 8439A CR 8439 A CR8439 A CR 8439A
- Authority
- CR
- Costa Rica
- Prior art keywords
- radio
- improving
- effectiveness
- labeled
- therapeutic drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1069—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from blood cells, e.g. the cancer being a myeloma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52847303P | 2003-12-11 | 2003-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8439A true CR8439A (es) | 2006-12-07 |
Family
ID=34676848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8439A CR8439A (es) | 2003-12-11 | 2006-06-07 | Metodo para mejorar la eficacia de drogas terapeuticas radio rotuladas |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1691838A2 (ru) |
| JP (1) | JP2007528874A (ru) |
| KR (1) | KR20060118542A (ru) |
| CN (1) | CN101031319A (ru) |
| AU (1) | AU2004296621A1 (ru) |
| BR (1) | BRPI0417517A (ru) |
| CA (1) | CA2546057A1 (ru) |
| CR (1) | CR8439A (ru) |
| EC (1) | ECSP066618A (ru) |
| IL (1) | IL175674A0 (ru) |
| MX (1) | MXPA06006683A (ru) |
| NO (1) | NO20063207L (ru) |
| RU (1) | RU2006124510A (ru) |
| WO (1) | WO2005056058A2 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI568453B (zh) * | 2011-11-22 | 2017-02-01 | 原創生醫股份有限公司 | 具有螯合型複合微胞之藥物載體及其應用 |
| CN106975078B (zh) * | 2017-03-31 | 2020-11-10 | 国家纳米科学中心 | 一种包含多钨酸钆的纳米材料作为增敏剂的用途 |
| WO2024013272A1 (en) * | 2022-07-13 | 2024-01-18 | Universite De Montpellier | Combined therapy with nanoparticles and radiopharmaceuticals |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR022404A1 (es) * | 1999-01-25 | 2002-09-04 | Photogen Inc | Metodo y agentes para la terapia de radiacion mejorada |
| AU2001249608A1 (en) * | 2000-03-28 | 2001-10-08 | Beth Israel Deaconess Medical Center | Bladder cancer-specific peptides for diagnosis and therapy |
| MXPA03006771A (es) * | 2001-01-29 | 2004-05-05 | Idec Pharma Corp | Anticuerpos modificados y metodos de uso. |
| CA2494372C (en) * | 2002-08-15 | 2013-05-28 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to trail receptors |
-
2004
- 2004-12-13 RU RU2006124510/15A patent/RU2006124510A/ru not_active Application Discontinuation
- 2004-12-13 WO PCT/IB2004/004428 patent/WO2005056058A2/en active Search and Examination
- 2004-12-13 CA CA002546057A patent/CA2546057A1/en not_active Abandoned
- 2004-12-13 AU AU2004296621A patent/AU2004296621A1/en not_active Abandoned
- 2004-12-13 KR KR1020067011322A patent/KR20060118542A/ko not_active Application Discontinuation
- 2004-12-13 CN CNA2004800369951A patent/CN101031319A/zh active Pending
- 2004-12-13 JP JP2006543664A patent/JP2007528874A/ja not_active Withdrawn
- 2004-12-13 BR BRPI0417517-4A patent/BRPI0417517A/pt not_active IP Right Cessation
- 2004-12-13 MX MXPA06006683A patent/MXPA06006683A/es unknown
- 2004-12-13 EP EP04817629A patent/EP1691838A2/en not_active Withdrawn
-
2006
- 2006-05-16 IL IL175674A patent/IL175674A0/en unknown
- 2006-06-07 CR CR8439A patent/CR8439A/es unknown
- 2006-06-08 EC EC2006006618A patent/ECSP066618A/es unknown
- 2006-07-10 NO NO20063207A patent/NO20063207L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL175674A0 (en) | 2006-09-05 |
| WO2005056058A3 (en) | 2006-04-13 |
| AU2004296621A1 (en) | 2005-06-23 |
| WO2005056058A2 (en) | 2005-06-23 |
| KR20060118542A (ko) | 2006-11-23 |
| RU2006124510A (ru) | 2008-01-20 |
| CN101031319A (zh) | 2007-09-05 |
| BRPI0417517A (pt) | 2007-03-06 |
| EP1691838A2 (en) | 2006-08-23 |
| JP2007528874A (ja) | 2007-10-18 |
| NO20063207L (no) | 2006-07-10 |
| ECSP066618A (es) | 2006-10-25 |
| CA2546057A1 (en) | 2005-06-23 |
| MXPA06006683A (es) | 2006-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY157661A (en) | Bendamustine pharmaceutical compositions | |
| AR049985A1 (es) | Tratamiento de combinacion para enfermedades malignas no hematologicas | |
| HN2003000039A (es) | 2-(PIRIMIDIN-2-ILAMINO)-PIRIDO[2,3-d]PIRIMIDIN-7-ONAS | |
| UY28860A1 (es) | Procedimiento para el tratamiento de trastornos premenstruales y otros trastornos sexuales femeninos | |
| ATE432279T1 (de) | Tricyclische delta-opioid-modulatoren | |
| CR20140108A (es) | Compuesto de ciclopropanoamina | |
| CR8380A (es) | Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos | |
| CO6361942A2 (es) | Terapia de combinacion con epoxicetonas peptidicas | |
| PA8654601A1 (es) | Agentes citotoxicos que comprenden taxanos nuevos | |
| GT200500127A (es) | Composiciones y metodos para el tratamiento de trastorno disforico premenstrual | |
| UY26456A1 (es) | Compuestos que fijan la estructura g-cuadruplex de los telomeros, triazinas de aplicación de dichos compuestos, la utilización de dichos compuestos como productos farmacéuticos y las asociaciones terapéuticas que los incluyen. | |
| MX2008008413A (es) | Composicion farmaceutica para el tratamiento de las enfermedades de las uñas. | |
| AR032293A1 (es) | Estuche farmaceutico | |
| AR058173A1 (es) | Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas | |
| CR8439A (es) | Metodo para mejorar la eficacia de drogas terapeuticas radio rotuladas | |
| BR0209645A (pt) | Oxazolo- e furopirimidinas e seu uso como medicamentos | |
| DK1699480T3 (da) | Allogent terapeutisk tumormiddel | |
| NI200800216A (es) | Uso de compuestos peptídicos de tpo y composiciones farmacéuticas en el tratamiento de la anemia | |
| Marcellin et al. | Viral hepatitis: impressive advances but still a long way to eradication of the disease | |
| AR065528A1 (es) | Forma de dosificacion que comprende 6-(3- coclobutil -2,3,4,5- tetrahidro -1h - benzo (d) azepin -7-iloxi)-n - metil- nicotinamida , metodo para producirla, su uso para preparar un medicamento y solucion o suspension que los comprende | |
| CO5050343A1 (es) | Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana | |
| CO2022017112A2 (es) | N-cianopirrolidinas con actividad como inhibidores de peptidasa específica de ubiquitina 30 | |
| CR8584A (es) | Piperazinas derivadas de urea para el tratamiento de la endometrosis | |
| CL2004000767A1 (es) | Unidad de dosificacion oral que comprende un agente antagonista de bombas de protones y excipientes de caracter basico; procedimiento para su preparacion, utiles para tratar enfermedades causadas por una secrecion aumentada de acidos gastricos. | |
| AU2003240545A8 (en) | Use of ramoplanin to treat diseases associated with the use of antibiotics |